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Abstract. Novel amphiphilic guanine derivatives, here named Gua1 and Gua2, have been prepared 
through few, simple and efficient synthetic steps. In ion transport experiments through phospholipid 
bilayers, carried out to evaluate their ability to mediate H
+
 transport, Gua2 showed high activity. 
When this compound was investigated for ion-selective transport activities, no major differences 
were observed in the behaviour with cations while, in the case of anions, selective activity was 
observed in the series I
-
>Br
-
>Cl
-
>F
-
. The bioactivity of these guanine analogues has been evaluated 
on a panel of human tumour and non-tumour cell lines in preliminary in vitro cytotoxicity assays, 
showing a relevant antiproliferative profile for Gua2. 
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Introduction 
 
Among the canonical nucleobases, guanine plays a special role, having an extraordinary ability to 
produce multiple hydrogen bonds and thus generate not only Watson-Crick interactions but also a 
variety of non-Watson-Crick specific recognition schemes [1]. Thus, either in the form of single 
base or nucleoside, or incorporated in guanine-rich oligonucleotides, guanine derivatives may result 
into higher order self-assembling arrangements, such as the G-quadruplex structures, which are 
complex three-dimensional architectures consisting of stacked G-tetrads stabilized by Na
+
 or K
+
 
cations [2-4]. 
As a general remark, the biological activity of guanines and guanosines is not only related to their 
incorporation into specific DNA and/or RNA sequences, but can be found also in single 
nucleosides/nucleotides and/or nucleoside analogues. The stringent need for effective antiviral 
drugs has been the main trigger for the research in the field of nucleoside analogues in the last three 
decades. These efforts have produced a plethora of new, diverse compounds, many of which 
endowed with relevant bioactivity [5,6]. Well known examples of antiviral modified guanosines are 
acyclovir [7], ganciclovir [8] and entecavir [9], which are currently adopted in clinic against HSV, 
CMV and HBV, respectively. In more recent years, the interest for nucleoside analogues has been 
rekindled also in the frame of a general revisitation of their potential as anticancer and antibacterial 
agents [10-14]. 
We recently described some amphiphilic guanosine analogues as model compounds of a still very 
poorly investigated class of guanosine derivatives [15]. Our basic idea was to contribute to 
“bridging the gap” – in terms of knowledge and applications - between naturally occurring 
hydrophilic guanosine-based compounds (nucleotides and their congeners), on one side, and 
artificial lipophilic derivatives, on the other, emerged as promising nanotechnological tools. In 
order to produce a small library of different amphiphilic derivatives, we elaborated a simple, 
general synthetic procedure to introduce various lipophilic and hydrophilic appendages at the ribose 
moiety, so to ensure the highest molecular diversity within very straightforward synthetic schemes. 
Studies on the ability of the synthesized compounds to transport ions through phospholipids 
bilayers showed interesting results in the case of compounds G5, G6 and G7 (Figure 1), which well 
correlated with their cytotoxicity on several human tumour cell lines. 
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Figure 1. Chemical structures of the amphiphilic derivatives of guanosine previously studied in our 
group [15]. 
 
These encouraging results prompted us to further expand the repertoire of amphiphilic guanosine 
derivatives to obtain optimized compounds with improved ionophore and/or antiproliferative 
activity. In this work, we report the synthesis and characterization of two novel guanine analogues, 
which, compared with the previously described derivatives, have simplified structures, lacking the 
ribose moiety and exhibiting a single structural motif directly attached to the nucleobase. Their ion 
transport ability through phospholipid membranes, as well as preliminary in vitro data on their 
antiproliferative activity on tumour and non tumour cell lines are also presented. 
 
Results and Discussion 
Chemistry. 
Intrigued by optimization processes in drug discovery aimed at screening extremely simplified 
structures, we have synthesized two novel derivatives, Gua1 and Gua2, depicted in Figure 2, as 
model compounds of a novel family of amphiphiles. These analogues share a common design, 
based on the derivatization of the N9 position of the guanine moiety with a single hydrophilic 
structural motif, resulting into differently decorated ribose-free species. 
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Figure 2. Chemical structures of the amphiphilic guanine derivatives studied in this work. 
 
The structural requirements explored in the design of Gua1 and Gua2 satisfy a general principle of 
atom economy and have been inspired by a recent work, in which high ion transport activity 
through lipid membranes has been found in a very simple construct, consisting of a benzothiazole-
aniline core functionalized with a single tetraethylene glycol chain [16]. Assuming that this 
heteroaromatic compound can be effectively replaced by a guanine residue, the insertion of 
hydrophilic groups at its N9 position should then add the overall polarity necessary to obtain an 
amphiphilic derivative, with sufficient water solubility and able to interact with lipid bilayers. 
In Gua1 and Gua2 a triethylene glycol chain and a trehalose residue, respectively, have been 
inserted into the guanine scaffold; these polar appendages have been selected on the basis of our 
previous data on amphiphilic guanosine derivatives, showing G5 and G6 (Figure 1), incorporating 
these structural motifs, as the most active compounds [15]. 
The target derivatives Gua1 and Gua2 have been obtained through a straightforward, flexible and 
efficient procedure, using a partially protected guanine building block as a common intermediate (2, 
Scheme 1). This was prepared from guanine in two simple steps, involving first the reaction with an 
excess of Boc anhydride in the presence of cat. DMAP, which gave the fully protected nucleobase 1 
[17]. Then the treatment with a satd NaHCO3 solution, essentially following a published procedure 
[18], allowed to selectively remove the Boc group at the N9 position. The resulting guanine 
derivative 2 was thus exploited in the coupling with either monomethoxytriethylene glycol, 
exposing a free primary alcohol group, or a fully Boc-protected trehalose monosuccinic acid 
derivative, synthesized as previously described [15] and exposing a COOH group (4, Scheme 1). In 
the first case the coupling was realized via a Mitsunobu reaction, in the latter via a standard DCC 
activation of the carboxylic function.  
Monomethoxytriethylene glycol, used for the synthesis of Gua1, is commercially available and has 
been coupled as such with protected guanine 2 using triphenylphosphine and DIAD as condensing 
agents in anhydrous THF. Target derivative 3 has been thus obtained in 90% yields after 
purification. 
For the synthesis of Gua2, guanine derivative 2 has been coupled with the disaccharide building 
block 4 in the presence of DCC/DMAP in anhydrous CH2Cl2, giving 5 in 95% yields after column 
chromatography. Following a previously described procedure, the used disaccharide 4 has been 
obtained in few, simple reactions starting from ’-D-trehalose. This is a symmetrical disaccharide 
widely represented in nature, having a peculiar ability to stabilize phospholipid membranes [19]. In 
addition it offers many favourable features in terms of synthetic manipulations, since it is a non-
reducing sugar, does not undergo mutarotation, and its O-glycosidic bond is pretty stable compared 
to other disaccharides [20,21]. The latter issue is of the utmost relevance considering that preformed 
disaccharides are privileged scaffolds for the synthesis of glyco-peptides, glyco-oligonucleotides or 
other hybrid compounds, but typically the acidic treatments required for the oligomer deprotection 
steps prevent their use and thus suitable glycomimetics have to be designed. Typically, these 
saccharide-based building blocks are obtained through several synthetic steps and are protected on 
the OH groups with base-labile acetyl groups [22-24]. In this strategy, the use of trehalose 
derivative 4, fully protected with acid-labile Boc groups, has allowed a unique protection scheme 
for adduct 5 so that target compound Gua2 can be obtained in a pure form through a single 
deprotection step. 
Clean removal of both Boc and tBu groups has been achieved treating the protected adducts 3 and 5 
with 10% TFA in anhydrous CH2Cl2, which gave the corresponding fully deprotected compounds 
in almost quantitative yields. Final compounds Gua1 and Gua2, as well as all the synthesized 
intermediates, have been fully characterized by 
1
H and 
13
C NMR and MS analysis. 
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Scheme 1. Synthesis of Gua1 and Gua2. Reaction conditions: a) Boc2O, DMAP, TEA, CH3CN, 4 
d, r.t., 51% yields; b) NaHCO3 satd. soln. in CH3OH, 1 h, 50 °C, 96% yields; c) 
CH3O(CH2CH2O)CH2CH2OH, PPh3, DIAD; THF, 12 h, r.t. 90%; d) Boc-protected trehalose 6-
monosuccinic acid (4), DCC, DMAP, 30 min, r.t., 95%; e) 10% TFA in CH2Cl2, 2 h, r.t., quant. R = 
Boc. 
 
Ion transport studies through lipid membranes. 
The ionophoric activity of compounds Gua1 and Gua2 has been investigated in large unilamellar 
vesicles (100 nm diameter, prepared by extrusion) with a 95:5 egg phosphatidylcholine (EYPC) and 
egg phosphatidylglycerol (EYPG) lipid composition. 
The ability of the ionophore to mediate a pH gradient collapse across the membrane has been 
measured using the pH-sensitive fluorescent dye HPTS (HPTS = 8-hydroxypyrene-1,3,6-trisulfonic 
acid, pKa = 7.2). In this assay the dye is entrapped inside the phospholipid vesicles prepared in 
HEPES buffer (pH 7.0) containing 100 mM NaCl and, after addition of the ionophore, a pH 
gradient of 0.6 pH units is applied by external addition of NaOH. The collapse of this 
transmembrane pH-gradient implies basification of the liposome inner water pool, which is 
signalled by an increase of the HPTS fluorescence emission. Therefore, the rate of the pH gradient 
collapse gives direct information on the transportation of OH
-
 (influx) or H
+
 (efflux) and indirect 
information on the correlated symport/antiport of counterions required to counterbalance the 
transmembrane ions movement. Figure 3a shows the typical kinetic profiles obtained upon addition 
of NaOH at 200 s and lyses of the liposomes by addition of Triton X-100 at 1400 s. 
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Figure 3. a) Normalized fluorescence change in HPTS emission as a function of time after addition 
of the base (50 L of 0.5 M NaOH) to 95:5 EYPC/EYPG LUVs (100 nm diameter) loaded with 
HPTS (0.1 mM HPTS, 0.17 mM total lipid concentration, 25 mM HEPES, 100 mM NaCl, pH 7.0), 
in the presence of 2% concentration of Gua1, Gua2, and G5. The concentration of the ionophores 
is given in percent with respect to the total lipid concentration. The control trace has been recorded 
in the absence of ionophore. (b) Plot of the observed rate constant for the transport process (kt, s
-1
) 
vs concentration for ionophore Gua2. 
 
Of the two guanine derivatives here investigated, only Gua2 shows interesting ionophoric activity 
while Gua1 is substantially inactive. Remarkably, Gua2 is about two times more active than G5, 
that was the most efficient ionophore within the previous series investigated ([15], Figure 1). This 
result suggests that the guanine nucleus and the trehalose subunit are essential, while the ribose 
moiety is not required, or even detrimental, for ionophoric activity. Control experiments, carried out 
separately on guanine and trehalose as isolated compounds, showed no activity (see Supplementary 
Content, Figure S1). Similar results were obtained also analysing the lipophilic derivative 6-tert-
butyldiphenylsilyl-trehalose [15], which is a monoprotected derivative of trehalose having similar 
polarity as Gua2, obtained as precursor of 6-monosuccinylated derivative 4. Even if this compound 
proved to be slightly more active than trehalose alone – see Figure S1, panel c – its effects are 
largely marginal in comparison with Gua2. Taken together, all these results converge in concluding 
that it’s the proper combination of structural motifs in Gua2 – the nucleobase and the disaccharide 
– responsible for the observed activity.  
On the other hand, the hydrophilic portion of Gua1 is probably too small and the compound is not 
able to permeabilize the phospholipid bilayer. A strong correlation between the size of the 
hydrophilic portion and the ionophoric activity has been indeed observed in the previous 
investigated series of guanosine derivatives as well as in somehow structurally related CyPLOS 
derivatives [25,26]. 
The activity of Gua2 depends on its concentration as shown in Figure 3b, which reports the 
observed pseudo-first-rate constants obtained by fitting the kinetic profiles recorded in the 
conditions of Figure 3a and in the presence of increasing concentrations of ionophore. The 
dependence of the rate constant from the concentration of Gua2 is linear, suggesting that the active 
species responsible for the transport process is monomeric. Interestingly, kinetic experiments 
performed in the conditions of Figure 3a but in the presence of K
+
 instead of Na
+
 indicate that the 
ionophoric activity of the two guanine derivatives is not influenced by the cation present in solution 
(see also below) suggesting that, as already observed with the guanosine derivatives of Figure 1, the 
potassium cation is not able to promote the assembly of guanine aggregates in membranes. This 
result confirms that simple guanine derivatives are not suitable to form G-quartet structures in 
phospholipid membranes under the studied concentration conditions, as conversely already 
observed with more complex guanosine-based systems [27,28]. To further exclude possible 
aggregation events occurring in solution when investigating Gua1 and Gua2 alone, or in the 
membrane when mixed with the examined phospholipids, DLS measurements have been carried out 
(see Supplementary Content). In the case of the isolated ionophores, analyzed at M concentrations, 
no aggregates could be observed, demonstrating that both Gua 1 and Gua2 do not tend to form 
supramolecular structures detectable under the used experimental set-up. Then, when mixed with 
the 95:5 EYPC/EYPG phospholipid at 2% mol/mol ratio, the size and morphology of the resulting 
aggregates were in no case sensibly altered. 
Selectivity in ion transport for Gua2 has been investigated with the HPTS assay using the protocol 
described above and in the presence of HEPES buffer containing the cation or the anion under 
investigation added as MCl or NaX salt, respectively [29]. The obtained results show similar 
transport rates in the presence of the first group alkali metals (Figure 4a) and a strong dependence 
on the nature of the halide present, with transport rates increasing from fluoride to iodide (Figure 
4b). Independence of the transport process from the nature of the cation and dependence from the 
nature of the anion is an evidence that the basification of the inner vesicular water pool signaled by 
HPTS correlates with OH
-
/X
-
antiport (or to the kinetically equivalent H
+
/X
-
symport). Accordingly, 
the kinetic traces of Figure 4a report on the transport of chloride which is present as the common 
counterion of all the cations used in this set of experiments. On the other hand, the selectivity 
sequence observed in the transport of halides follows the lyotropic series, with the less hydrated 
ions transported faster than the more hydrated ones. Therefore, the transport process appears 
governed by the translocation of the anion and rate-limited by the cost of its dehydration. 
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Figure 4. a) Cation selectivity of Gua2 (2 %) determined by the HPTS assay (MCl (100 mM), pH 
7.0, base pulse by addition of MOH (50 L, 0.5 M)). b) Anion selectivity of Gua2 (2 %) 
determined by the HPTS assay (NaX (100 mM), pH 7.0, base pulse by addition of NaOH (50 L, 
0.5 M)). The kinetics were corrected for spontaneous permeation of the different anions. Other 
conditions as specified in Figure 3. 
 
The inactivity of Gua1 and the activity and ion selectivity of Gua2 compare well with the 
ionophoric behavior observed with the guanosine derivatives G1-G7 and we therefore propose the 
same mechanism of action for these structurally related compounds. In this model, Gua2 inserts in 
the membrane with the guanine moiety anchored on the surface and the trehalose subunit dipped in 
the phospholipid bilayer. The effect of the polar sugar is a destabilization of the membrane with the 
formation of disordered patches, characterised by an increased permeability which allows the transit 
of the ions in a process mainly governed by the cost of the anion dehydration. Interestingly, removal 
of the ribose moiety between the nucleobase and the trehalose results in an increase of activity, 
probably related to a better insertion mode of the ionophore in the membrane due to steric factors or 
to a more favourable hydrophilic/hydrophobic balance. 
In vitro bioscreenings for cytotoxic activity. 
Although several amphiphiles based on canonical nucleobases are described in the literature, very 
few examples are known for guanine derivatives and their potential in biomedical applications is 
almost completely unexplored. In this frame, our group recently showed that guanosine-based 
systems are endowed with biological/biomedical potential, displaying an interesting 
antiproliferative activity towards certain types of human cancer cells not directly related to their 
DNA and RNA-targeting properties [15]. These findings prompted us to test Gua1 and Gua2 for 
cytotoxic activity on a selected panel of human cell lines. Bioscreenings are useful in vitro assays to 
validate a particular bioactivity and the herein reported experimental procedure allows the 
estimation of the cytotoxicity by a “cell survival index” determined by monitoring the cellular 
metabolic activity and the live/dead cells ratio. The results are reported both in concentration-effect 
curves (Figure 5) and in terms of IC50 values (Table 1). Data concerning cisplatin (cDDP) - a 
positive control for cytotoxic activity - are included for comparison.  
The most important outcome emerging from these assays is that Gua2 exhibits a considerable 
bioactivity pattern characterized by a non-selective cytotoxicity against human cancer and non-
cancer cell lines of different histological origins. The corresponding IC50 values, ranging in the low 
micromolar range, are comparable to those found for cisplatin and are consistent with a moderate-
to-strong cytotoxic effect. Indeed, in HaCaT and MCF-7 the Gua2 effects on cell growth are even 
more pronounced than those of cisplatin. Conversely, in all cases Gua1 shows IC50 values >10
2
 
µM, without causing any apparent effect on cell viability and/or proliferation. 
A B
C D
 
Figure 5. Cell survival index values, evaluated by MTT assay and total cell count, in HaCaT (panel 
A), MCF-7 (panel B), DU145 (panel C) and SH-SY5Y (panel D) cell lines incubated for 48 h with a 
range of concentrations (1→100 µM) of Gua1 and Gua2 (color bars) and with cisplatin (cDDP, 
solid line), here used as positive control for cytotoxicity. Data are expressed as percentage of 
untreated control cells and are reported as mean of four independent experiments ± SEM. 
 Table 1 - IC50
a
 values (μM) for Gua1 and Gua2 in the indicated cell lines following 48 h of 
incubation. Positive control for cytotoxicity was performed using cisplatin (cDDP). 
 
Cell lines cDDP Gua1 Gua2 G5
b
 
HaCaT 7 ± 2.5 > 10
2
 1 ± 0.8 n.d. 
MCF7 25 ± 4 > 10
2
 5 ± 2 17 ± 5
b
 
DU145 20 ± 5 > 10
2
 25 ± 3 n.d. 
SH-SY5Y 2 ± 0.9 > 10
2
 80 ± 5 n.d. 
a 
IC50 values are reported as mean ± SEM (n = 24) of 3 independent experiments; 
b 
data from ref. 
15;  n.d. = not determined. 
 
Conclusions. 
In this work we have described the synthesis and characterization of two new guanine analogues, 
respectively conjugated with an oligoethylene glycol chain and a trehalose residue, proposed as 
model compounds of a new family of easily synthetically accessible amphiphiles. An efficient and 
versatile synthetic scheme has been adopted for their preparation, involving a partially protected 
guanine derivative as a common intermediate, able to react at the sole N9 position either with 
alcohols, via a Mitsunobu procedure, or with carboxylic acids, via standard DCC activation. After 
coupling, in both cases the target compounds have been obtained through a single acidic 
deprotection step. This synthetic strategy has been particularly efficient in the case of the 
disaccharide-conjugated derivative Gua2, realized using the valuable fully Boc-protected trehalose 
building block 4, of interest in a variety of glyco-conjugations. 
Gua1 and Gua2, analyzed in their ability to transport ions through lipid bilayers, showed a very 
different behaviour. High activity has been observed only in the latter compound, having also a 
marked specificity in the transport of anions, thus indicating that the polar appendage attached to 
the nucleobase is the most relevant structural motif for this property. In comparison with the 
previously investigated guanosine derivatives [15], Gua2 is about two times more efficient than the 
corresponding trehalose-containing derivative G5. Therefore, the proposed structural simplification 
approach turned out to be successful in producing enhanced ionophoric activity. 
The bioactivity of these new compounds has been investigated on a panel of human cancer and 
healthy cells. Preliminary data showed that Gua1 has a negligible antiproliferative profile, while 
remarkable in vitro activity – higher than that of cisplatin, here used as a reference compound - has 
been found in Gua2 when tested against human MCF-7 and HaCaT cell lines. 
Thus, in line with previous studies, carried out by us [15] and others [30], remarkably the 
anionophoric activity of the tested compounds has been found to well correlate with their in vitro 
bioactivity. 
If in general no straightforward cause-effect relationship can be invoked to exist between ion 
transport properties and cytotoxicity of small molecules, these results suggest that anion transport 
might play a significant role in the mechanism of action of these compounds in cell. In fact, it is 
known that the anion transport can influence the sophisticated mechanisms of regulation of 
intracellular pH by determining changes that can trigger apoptosis [31]. Thus, the search for 
structural motifs ensuring improved anion transport abilities could be extremely helpful in the 
rational design of novel optimized drugs with a more favourable pharmacological profile. 
Starting from the promising data on Gua2, our future studies in this field will be addressed to 
investigate a larger set of guanine analogues, aiming at obtaining more specific bioactive 
compounds. 
 Experimental Section. 
 
General Methods. 
All the reagents were of the highest commercially available quality and were used as received. TLC 
analyses were carried out on silica gel plates from Merck (60, F254). Reaction products on TLC 
plates were visualized by UV light and then by treatment with a 10 % Ce(SO4)2/H2SO4 aqueous 
solution. For column chromatography, silica gel from Merck (Kieselgel 40, 0.063-0.200 mm) was 
used. NMR spectra were recorded on Varian Gemini 200 and Varian Inova 500 spectrometers, as 
specified. All the chemical shifts are expressed in ppm with respect to the residual solvent signal. 
Peak assignments have been carried out on the basis of standard H-H COSY and HSQC 
experiments. For the ESI MS analyses, a Waters Micromass ZQ instrument – equipped with an 
Electrospray source – was used in the positive mode. MALDI TOF mass spectrometric analyses 
were performed on a PerSeptive Biosystems Voyager-De Pro MALDI mass spectrometer in the 
Linear mode. 
 
Abbreviations. 
The following abbreviations have been used throughout the text: AcOEt = ethyl acetate; Boc = tert-
butoxycarbonyl; Boc2O = Boc anhydride; DCC = dicyclohexylcarbodiimide; DIAD = 
diisopropylazodicarboxylate; DMAP = 4-(N,N-dimethylamino)pyridine; DMF = N,N-
dimethylformamide; PPh3 = triphenylphosphine; tBu = tert-butyl; TEA = triethylamine; TFA = 
trifluoroacetic acid; THF = tetrahydrofuran. 
 
Synthesis of fully protected triethylene glycol derivative 3. 
Partially protected guanine derivative 2 (40 mg, 0.098 mmol), synthesized from guanine in two 
steps [17,18], and monomethoxytriethylene glycol (33 L, 34 mg, 0.21 mmol) were dissolved under 
stirring in anhydrous THF (3.0 mL) and the resulting mixture was then treated with PPh3 (54 mg, 
0.21 mmol) and DIAD (41 L, 42 mg, 0.21 mmol) at r.t. After 12 h, TLC monitoring showed the 
complete disappearance of the guanine-containing starting material and the formation of a unique 
new compound. The reaction mixture was then taken to dryness under reduced pressure and the 
residue, redissolved in AcOEt, was then applied to a silica gel column, eluted with n-hexane/AcOEt 
(1:9, v/v). Collection of the appropriate fractions gave pure target compound 3 (49 mg, 0.088 
mmol), obtained in 90% yield. 
3: oil. Rf = 0.5 in AcOEt. 
1
H NMR (200 MHz, CDCl3)  at: 8.07 (s, 1H, H-8); 4.38 (apparent t, J = 
4.8 and 5.0 Hz, 2H, CH2OCH3); 3.78 (apparent t, J = 4.8 and 5.0 Hz, 2H, CH2CH2N); 3.45-3.38 
(overlapped signals, 8H, 2x CH2OCH2); 3.36 (s, 3H, OCH3); 1.70 (s, 9H, tBu); 1.39 (s, 18H, 2x 
Boc). 
13
C NMR (50 MHz, CDCl3)  at: 161.2 (C6); 152.8 (C2); 151.7 (C4); 150.8 (CO Boc); 141.2 
(C8); 121.6 (C5); 84.4 (quaternary C of tBu); 82.9 (quaternary C of Boc); 71.6, 71.3, 70.1, 68.5 and 
68.3 (5x CH2O); 59.1 (OCH3); 46.6 (CH2N); 28.3 (CH3 groups of tBu); 27.9 (CH3 groups of Boc). 
ESI-MS (positive ions): for C26H43N5O8, calcd. 553.31; found m/z: 554.61 [M+H
+
, 25%]; 576.72 
[M+Na
+
, 100%]; 592.79 [M+K
+
, 30%]. HRMS (MALDI-TOF): calcd. for C26H43N5O8Na = 
576.3009; found m/z: 576.3021 [M + Na
+
]. 
 
Synthesis of Gua1. 
Fully protected derivative 3 (25 mg, 0.045 mmol) was left in contact with a 10% TFA solution in 
anhydrous CH2Cl2 (1.0 mL) at r.t. under stirring. After 2 h, TLC monitoring showed the complete 
disappearance of the starting material and formation of a unique new compound. The reaction 
mixture was then diluted with CH2Cl2, taken to dryness under reduced pressure and the residue 
coevaporated several times with 2-propanol, affording pure Gua1 (13 mg, 0.045 mmol) in almost 
quantitative yields. 
Gua1: oil. Rf = 0.2 in AcOEt. 
1
H NMR (200 MHz, CD3OD)  at: 9.00 (s, 1H, H-8); 4.41 (t, J = 4.8 
and 4.8 Hz, 2H, CH2OCH3); 3.86 (apparent t, J = 4.8 and 5.0 Hz, 2H, CH2CH2N); 3.64-3.48 
(overlapped signals, 8H, 2x CH2OCH2); 3.34 (s, 3H, OCH3). 
13
C NMR (50 MHz, CD3OD)  at: 
157.2 (C6); 155.4 (C2); 151.7 (C4); 139.1 (C8); 115.3 (C5); 71.5, 71.2, 70.0, 68.4 and 68.2 (5x 
CH2O); 59.1 (OCH3); 46.5 (CH2N). ESI-MS (positive ions): for C12H19N5O4, calcd. 297.14; found 
m/z: 298.54 [M+H
+
, 21%]; 320.64 [M+Na
+
, 100%]; 336.71 [M+K
+
, 36%]. HRMS (MALDI-TOF): 
calcd. for C12H19N5O4Na = 320.1335; found m/z: 320.1361 [M + Na
+
]. 
 
Synthesis of fully protected trehalose derivative 5. 
Partially protected guanine derivative 2 (8.0 mg, 0.020 mmol) and Boc-protected trehalose 6-
monosuccinic acid 4 (24 mg, 0.021 mmol), synthesized as previously described [15]. were 
dissolved under stirring in anhydrous CH2Cl2 (1.0 mL) in the presence of DCC (6.0 mg, 0.03 mmol) 
and DMAP (0.2 mg, 0.002 mmol). After 30 min at r.t. TLC monitoring showed the complete 
disappearance of the starting materials and the formation of a unique new compound. The reaction 
mixture was then taken to dryness under reduced pressure and the residue, redissolved in AcOEt, 
was then applied to a silica gel column, eluted with n-hexane/AcOEt (3:2, v/v). Collection of the 
appropriate fractions gave pure target compound 5 (29 mg, 0.019 mmol), obtained in 95% yield. 
5: amorphous solid. Rf = 0.7 in n-hexane/AcOEt (1:1, v/v). 
1
H NMR (500 MHz, CDCl3)  at: 8.57 
(s, 1H, H-8); 5.25 (apparent t, J = 3.5 and 3.5 Hz, overlapped signals, 2H, H-1’ and H-1’’); 5.21 
(overlapped signals, 2H, H-3’ and H-3’’); 5.01-4.94 (overlapped signals, 2H, H-4’ and H-4’’); 4.90-
4.85 (overlapped signals, 2H, H-2’ and H-2’’); 4.43-4.40 (m, 1H, Ha-6’); 4.39-4.36 (m, 1H, Ha-6’’); 
4.32-4.23 (overlapped signals, 2H, H-5’ and H-5’’); 4.08-4.07 (m, 1H, Hb-6’); 4.01-3.98 (m, 1H, 
Hb-6’’); 3.68 (m, 2H, CH2 succinic residue); 2.87 (t, J = 6.0 and 6.0 Hz, 2H, CH2 succinic residue); 
1.72 (s, 9H, tBu); 1.49, 1.48, 1.47, 1.46, 1.45, 1.44 and 1.43 (s’s, 9H each, 7x Boc); 1.31 and 1.29 
(s’s, 9H each, 2x Boc). 13C NMR (125 MHz, CDCl3)  at: 171.6 and 169.5 (CO of the succinic ester 
and amide); 161.3 (C6); 153.2 (C2); 152.0 and 151.1 (CO of the Boc groups); 150.7 (C4); 138.8 
(C8); 121.8 (C5); 94.5 (C-1’, C-1’’); 84.7 (quaternary C of tBu), 83.2, 83.0, 82.8, 82.5, 82.2 
(quaternary C of the Boc groups); 73.0 (C-3’, C-3’’); 72.1 (C-2’, C-2’’); 70.4 (C-4’, C-4’’); 68.1 
(C-5’, C-5’); 63.3 (C-6’); 61.6 (C-6’’); 55.7 (CH2 succinic residue); 28.2 (CH3 groups of tBu), 27.8, 
27.7, 25.4 and 24.7 (CH3 groups of Boc). ESI-MS (positive ions): for C70H109N5O32, calcd. 1531.71; 
found m/z: 1532.11 [M+H
+
, 27%]; 1554.21 [M+Na
+
, 100%]; 1571.10 [M+K
+
, 46%]. HRMS 
(MALDI-TOF): calcd. for C70H109N5O32Na = 1554.6953; found m/z: 1554.6979 [M + Na
+
]. 
 
Synthesis of Gua2. 
Fully protected derivative 5 (25 mg, 0.016 mmol) was left in contact with a 10% TFA solution in 
anhydrous CH2Cl2 (1.0 mL) at r.t. under stirring. After 2 h, TLC monitoring showed the complete 
disappearance of the starting material and the formation of a unique new compound. The reaction 
mixture was then diluted with CH2Cl2, taken to dryness under reduced pressure and the residue 
coevaporated several times with 2-propanol, affording pure Gua2 (10 mg, 0.016 mmol) in almost 
quantitative yields. 
Gua2: amorphous solid. Rf = 0.5 in AcOEt/CH3OH (5:1, v/v). 
1
H NMR (400 MHz, CD3OD), broad, 
not well resolved signals with  at: 8.68 (s, 1H, H-8); 5.31 (overlapped signals, 2H, H-1’ and H-
1’’); 5.26 (overlapped signals, 2H, H-3’ and H-3’’); 5.09-4.98 (overlapped signals, 2H, H-4’ and H-
4’’); 4.93-4.87 (overlapped signals, 2H, H-2’ and H-2’’); 4.47-4.44 (m, 1H, Ha-6’); 4.40-4.38 (m, 
1H, Ha-6’’); 4.35-4.25 (overlapped signals, 2H, H-5’ and H-5’’); 4.12-4.10 (m, 1H, Hb-6’); 4.08-
4.02 (m, 1H, Hb-6’’); 3.72 (m, 2H, CH2 succinic residue); 2.92 (m, 2H, CH2 succinic residue). 
13
C 
NMR (100 MHz, CD3OD)  at: 174.9 and 168.8 (CO of the succinic ester and amide); 162.0 (C6); 
154.4 (C2); 151.6 (C4); 140.6 (C8); 120.2 (C5); 95.7 (C-1’, C-1’’); 75.6 (C-3’, C-3’’); 73.6 (C-2’, 
C-2’’); 72.4 (C-4’, C-4’’); 71.7 (C-5’, C-5’); 65.3 (C-6’); 63.1 (C-6’’); 56.9 (CH2 succinic residue). 
ESI-MS (positive ions): for C21H29N5O14, calcd. 575.17; found m/z: 576.85 [M+H
+
, 100%]; 598.75 
[M+Na
+
, 55%]; 614.70 [M+K
+
, 30%]. HRMS (MALDI-TOF): calcd. for C21H29N5O14Na = 
598.1609; found m/z: 598.1640 [M + Na
+
]. 
 
Ionophoric activity. 
L-α-phosphatidyl-DL-glycerol sodium salt (EYPG, 20 mg/mL chloroform solution) was purchased 
from Avanti Polar Lipids; egg yolk phosphatidylcholine (EYPC, 100 mg/mL chloroform solution) 
and 8-hydroxypyrene-1,3,6-trisulfonic acid trisodium salt (HPTS) were from Sigma; Triton
®
 X-100 
and HEPES buffer were from Fluka; all salts were of the best grade available from Aldrich and 
were used without further purification. 
Liposomes were prepared by extrusion using a 10 mL Lipex
TM 
Thermobarrel EXTRUDER 
(Northern Lipids Inc.) connected to a thermostatic bath (25°C if not otherwise indicated). The 100 
nm polycarbonate membranes were Nucleopore Track-Etch Membranes from Whatman. 
Fluorescence spectra were recorded on a Varian Cary Eclipse fluorescence spectrophotometer. All 
fluorimetric measurements were performed at 25 °C. The ionophores concentration is given in 
percent with respect to the total concentration of lipids. Mother solutions of ionophores were 
prepared in methanol. Control experiments showed that the amount of methanol added to the 
vesicular suspension in the different experiments (maximum amount 2.0 % in volume) did not 
affect the permeability of the membrane. 
 
HPTS assay. 
A mixture of 150 µL of EYPC chloroform solution (100 mg/mL, 20 µmol) and 40 µL of EYPG 
chloroform solution (20 mg/mL, 1 µmol) was first evaporated under Ar-flux to form a thin film and 
then dried under high vacuum for 3 h. The lipid cake was hydrated in 1.5 mL of 0.1 mM HPTS 
solution (HEPES 25 mM, 100 mMNaCl, pH 7) for 30 min at 40°C. The lipid suspension was 
submitted to 5 freeze-thaw cycles (196°C/40°C) using liquid nitrogen and a thermostatic bath, and 
then extruded under nitrogen pressure (15 bar) at room temperature (10 extrusions through a 0.1 µm 
polycarbonate membrane). 
The LUV suspension was separated from extravesicular dye by size exclusion chromatography 
(SEC) (stationary phase: pre-packed column Sephadex™ G-25, mobile phase: HEPES buffer) and 
diluted with HEPES buffer to give a stock solution with a lipid concentration of 5 mM (assuming 
100% of lipids were incorporated into liposomes). 104 µL of the lipid suspension were placed in a 
fluorimetric cell, diluted to 3040 µL with the same buffer solution used for the liposome preparation 
and kept under gently stirring. The total lipid concentration in the fluorimetric cell was 0.17 mM. 
An aliquot of solution of the ionophore in MeOH (10-50 µL of the appropriate mother solution in 
order to obtain the desired molcompound/mollipid ratio) was then added to the lipid suspension and the 
cell was incubated at 25°C for 10 min. 
After incubation the time course of the fluorescence emission was recorded for 200 s (λex1=460 nm, 
λex2= 403 nm, λem= 510 nm) and then 50 μL of 0.5 M NaOH were rapidly added through an injector 
port and the fluorescence emission was recorded for 1200 s. Maximal changes in dye emission were 
obtained by final lysis of the liposomes with a detergent (40 μL of 5% aqueous Triton® X-100). The 
data set consists of emission intensities at 510 nm modulated by alternating excitation at 403 nm 
and 460 nm on a 0.5+0.5 s cycle. The concentration of the conjugate base form of HPTS is related 
to the emission intensity at 510 nm during the period in which the dye is excited at 460 nm (E460) 
while the concentration of the protonated form is related to the emission intensity at 510 nm during 
the period in which the dye is excited at 403 nm (E403). Fluorescence time courses were normalized 
using the following equation, where the subscripts 0, ∞ and t denote the emission ratio before the 
base pulse, after detergent lysis, and at an intermediate time, respectively.  
 
 
 
Determination of cation and anion selectivity with the HPTS assay. 
The vesicle suspension (104 L stock solution, prepared as described above) was placed in a 
fluorimetric cell and diluted to 3040 L with the appropriate buffer solution (25 mM HEPES pH 7, 
100 mM MCl with M = Li
+
, Na
+
, K
+
, Rb
+
, Cs
+
, or 100 mM NaX with X = F
-
, Cl
-
, Br
-
, I
-
). The total 
lipid concentration in the fluorimetric cell was 0.17 mM. An aliquot of MeOH solution of the 
ionophore (10-50 L of the appropriate mother solution in order to obtain the desired 
molcompound/mollipid ratio) was then added to the lipid suspension and the cell was incubated at 25 °C 
for 30 min. HPTS emission was monitored at 510 nm and excitation wavelengths of 403 and 460 
nm were used concurrently. After incubation, the time course of fluorescence was recorded for 200 
s and then 50 L of 0.5 M MOH (with M = Li+, Na+, K+, Rb+, Cs+ depending on the cation present 
in the extravesicular buffer solution) were rapidly added through an injector port and the 
fluorescence emission was recorded for 1200 s. Maximal changes in dye emission were obtained by 
final lysis of the liposomes with a detergent (40 L of 5% aqueous solution Triton® X-100). The 
extent of transport was calculated and normalized as previously described. 
 
Cell cultures and in vitro bioscreenings. 
Human MCF-7 breast adenocarcinoma cells, human neuroblastoma SH-SY5Y cell line, human  
prostate cancer DU145 cell line and human HaCaT keratinocytes were all purchased from ATCC 
(American Type Culture Collection, Manassas, Virginia, USA). MCF-7 and SH-SY5Y cells were 
grown in RPMI 1640 medium (Invitrogen, Paisley, UK), whereas DU145 and HaCaT cells were 
grown in DMEM (Invitrogen, Paisley, UK). Media were supplemented with 10% fetal bovine 
serum (FBS, Cambrex, Verviers, Belgium), L-glutamine (2 mM, Sigma, Milan, Italy), penicillin 
(100 units/ml, Sigma) and streptomycin (100 μg/ml, Sigma), according to ATCC recommendations. 
The cells were cultured in a humidified air 95% carbon dioxide (CO2) 5% atmosphere at 37 °C. 
The bioactivity of the guanine derivatives Gua1 and Gua2 was investigated through the estimation 
of a “cell survival index”, arising from the combination of cell viability evaluation with cell 
counting. Cells were inoculated in a 96-microwell culture plates at density of 10
4
 cells/well and  
allowed to grow for 24 h. The medium was then replaced with fresh medium and cells were treated 
for further 48 h with a range of concentrations (1→100 μM) of Gua1 and Gua2. Cell viability was 
evaluated with the MTT assay procedure based on the redox ability of living mitochondria, which 
measures the level of mitochondrial dehydrogenase activity using the yellow 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, Sigma) as substrate [32]. Cell number was 
determined by TC10 automated cell counter (Bio-Rad, Milan, Italy), providing an accurate and 
reproducible total count of cells and a live/dead ratio in one step [33]. The calculation of the 
concentration required to inhibit the net increase in the cell number and viability by 50% (IC50) is 
based on plots of data carried out in triplicates and repeated three times. IC50 values were obtained 
by means of a dose response curve by nonlinear regression using a curve fitting program, GraphPad 
Prism 5.0, and are expressed as mean ± SEM. 
 
Statistical Analysis. 
All data were presented as mean ± SEM. The statistical analysis was performed using Graph-Pad 
Prism (Graph-Pad software Inc., San Diego, CA) and ANOVA test for multiple comparisons was 
performed followed by Bonferroni's test. 
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